GALA RENEE D 4

What Happened
Gala Renee D, President & CEO of Jazz Pharmaceuticals (JAZZ), had 7,065 shares withheld on March 5, 2026 to cover tax obligations tied to the vesting of previously granted restricted stock units (RSUs). The withholding was recorded at $188.69 per share, totaling approximately $1,333,095. This was a tax-withholding disposition (code F), not an open-market sale.

Key Details

• Transaction date and price: March 5, 2026 — 7,065 shares at $188.69 each.
• Transaction value: Approximately $1,333,095 withheld for taxes.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnote: F1 — Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.
• Filing: Form 4 filed March 9, 2026; transaction occurred March 5, 2026 — filing appears timely (within two business days).

Context
Tax-withholding dispositions are routine when RSUs vest and do not represent an insider selling shares on the open market. Code F indicates shares were retained by the company/broker to cover tax liabilities rather than being sold as a signal of sentiment.